Michel Tohme
Overview
Explore the profile of Michel Tohme including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wadhwa P, Thielemans K, Efthimiou N, Wangerin K, Keat N, Emond E, et al.
Methods
. 2020 Feb;
185:110-119.
PMID: 32006678
This work demonstrates how computational and physical modelling of the positron emission tomography (PET) image acquisition process for a state-of-the-art integrated PET and magnetic resonance imaging (PET-MR) system can produce...
2.
Gong K, Zhou J, Tohme M, Judenhofer M, Yang Y, Qi J
IEEE Trans Med Imaging
. 2017 Jun;
36(10):2179-2188.
PMID: 28613163
An accurate system matrix is essential in positron emission tomography (PET) for reconstructing high quality images. To reduce storage size and image reconstruction time, we factor the system matrix into...
3.
Yang J, Jian Y, Tohme M, Behr S, Vigneron D, Majumdar S, et al.
EJNMMI Phys
. 2016 Mar;
2(Suppl 1):A68.
PMID: 26956328
No abstract available.
4.
Khalighi M, Delso G, Tohme M, Iagaru A, Zaharchuk G
EJNMMI Phys
. 2016 Mar;
2(Suppl 1):A60.
PMID: 26956320
No abstract available.
5.
Alauddin M, Shahinian A, Park R, Tohme M, Fissekis J, Conti P
Eur J Nucl Med Mol Imaging
. 2007 Jan;
34(6):822-9.
PMID: 17206416
Purpose: FIAU and FEAU were evaluated in vitro and in vivo as markers for HSV1-tk gene expression. Methods: In vitro and biodistribution studies were performed in wild type and transduced...
6.
Chen X, Park R, Khankaldyyan V, Gonzales-Gomez I, Tohme M, Moats R, et al.
Mol Imaging Biol
. 2005 Nov;
8(1):9-15.
PMID: 16315003
Purpose: EMD 121974, a potent cyclic RGD peptide inhibitor of alphav-integrins, demonstrated effectiveness in suppressing brain tumor growth in both preclinical models and phases I/II clinical trials. The ability to...
7.
Jadvar H, Xiankui L, Shahinian A, Park R, Tohme M, Pinski J, et al.
Mol Imaging
. 2005 Aug;
4(2):91-7.
PMID: 16105512
We hypothesized that the glucose metabolism of prostate cancer is modulated by androgen. We performed in vivo biodistribution and imaging studies of [F-18] fluorodeoxyglucose (FDG) accumulation in androgen-sensitive (CWR-22) and...
8.
Chen X, Sievers E, Hou Y, Park R, Tohme M, Bart R, et al.
Neoplasia
. 2005 Apr;
7(3):271-9.
PMID: 15799827
A series of radiolabeled cyclic arginine-glycine-aspartic acid (RGD) peptide ligands for cell adhesion molecule integrin alpha v beta 3-targeted tumor angiogenesis targeting are being developed in our laboratory. In this...
9.
Alauddin M, Shahinian A, Park R, Tohme M, Fissekis J, Conti P
J Nucl Med
. 2004 Dec;
45(12):2063-9.
PMID: 15585483
Unlabelled: 2'-deoxy-2'-(18)F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil ((18)F-FFAU) has been synthesized and evaluated in HT-29 cells as a potential PET agent for herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene expression. Methods: 2-Deoxy-2-(18)F-fluoro-1,3,5-tri-O-benzoyl-alpha-D-arabinofuranose was...
10.
Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, et al.
J Nucl Med
. 2004 Oct;
45(10):1776-83.
PMID: 15471848
Unlabelled: The alphav-integrins, cell adhesion molecules that are highly expressed on activated endothelial cells and tumor cells but not on dormant endothelial cells or normal cells, present an attractive target...